Objectives: Assessment of glycodelin (GD) as a marker for unruptured ectopic pregnancy (EP) in the first trimester of pregnancy. Materials and Methods: This case-control study was conducted during June 2016 to May 2017 in the Obstetrics and Gynecological Department of Baghdad University at Baghdad teaching hospital/medical city complex. In this study, 100 pregnant women in their first trimester of pregnancy were included after clinical and ultrasonic findings. Results: Based on the results, GD levels in EP were significantly lower than those with normal intrauterine pregnancy (1.58 ± 1.18 vs. 30.1 ± 11.9). In addition, using receiver operator curve analysis, the cut-off GD level of 9.5 and less had acceptable validity results (100% sensitivity, 100% specificity, 95% positive predictive value, 100% negative predictive value, and accuracy 100%) to predict EP. Conclusions: In general, serum GD is considered as an excellent predictor of unruptured EP.
Background: Polycystic ovary syndrome (PCOS) is a common disorder in women in the reproductive age associated with disturbance of reproductive, endocrine and metabolic functions. The pathophysiology of PCOS appears to be multifactorial and polygenic.Objective: To measure the level of prostate –specific antigen (PSA) and to evaluate the value of prostatic specific antigen as a marker of hyperandrogenism in women with PCOS.Patients and Methods: One hundred women were entrolled in this study, 50 women were PCOS group and the remainder was healthy women served as control group. Hormonal profile (serum testosterone, luteinizing hormone (LH), follicle stimulating hormone (FSH) levels were measured. Ferriman-Gallway Score (FGS) was assessed. Serum prostate specific antigen level was measured in both groups. Correlation between PSA level and (LH/FSH, testosterone and FGS) were evaluated.Result: Mean serum PSA level was significantly higher in PCOS women compared to control women (0.15+0.09, 0.016+0.003) respectively with P value < 0.05 ). Serum PSA level in women with PCOS had significant positive correlation with FGS, LH/FSH ratio and serum testosterone with r values: 0.964, 0.988, 0.922 respectively. There was a strong correlation between serum PSA levels with the degree of hirsutism as evaluated by Ferriman –Gallway score . Serum PSA level in the 1st group ( 4-8 ) was 0.07+0.009, in the 2 nd group ( FGS9-12 ) was 0.1+0.06 and in the 3 rd group ( FGS 13-16 ) was 0.3+0.03 .Conclusion: Prostate – specific antigen level is significantly higher in women with PCOS and correlate positively with LH/FSH, testosterone and Ferriman-Gallway score. It is also concluded that the higher score of hirsutism correlate with the higher serum PSA level.
Background: Preterm labor and related prematurity are predisposing factors that increase perinatal morbidity and mortality. Acute phase reactants are inflammatory markers which are positive and negative reactants explained by the reaction of reactants to the subclinical infection that are commonly associated with preterm labor. Objectives: To assess the role of acute phase reactants in pregnant women with preterm delivery. Patients and method: A case control study conducted in Gynecological Department of Baghdad Teaching Hospital from 1st February 2021 to 30th October 2021, on one hundred pregnant women with gestational age (28weeks - 36weeks+6days) who attended outpatient clinic; fifty pregnant women with established preterm labor as case group and fifty pregnant women with no signs and symptoms of preterm labor as control group. Data was collected using structured questionnaire included demographic features, and biochemical parameters (serum ferritin (ng/ml), albumin (gm/dl), fibrinogen (mg/dl), and calcium (mg/dl) . Results: Mean±SD serum ferritin in control group was (46.2 ± 16.2 ng/ml) while in case group (52.47 ± 11.6ng/ml) with significant difference between both groups (P=0.03), mean±SD serum albumin in control group (3.18 ± 0.31 ng/ml) while in case group (2.92 ± 0.39) with highly significant difference between both groups (P<0.001). Validity test of serum ferritin at cutoff ≥ 52.7 (ng/ml) in case group was as follows: Sensitivity (94%), specificity (90%), negative predictive value (94%), positive predictive value (90%) and the accuracy was (92%). The validity test of serum albumin at cutoff ≤ 3.06 (gm/dl) to detect the preterm labor as follows: Sensitivity (78%), specificity (86%), negative predictive value (78%), positive predictive value (83%) and the accuracy was (84%). Mean±SD serum fibrinogen in control group was (400.9 ± 38.1) while in case group was (410.7 ± 51.2) with no significant difference between both groups (P=0.1). Mean±SD serum calcium in control group was (8.1 ± 0.7) while in case group was (7.92 ± 0.5) with no significant difference between both groups (P=0.1). Conclusion: serum ferritin and albumin can be used in prediction of preterm labor in 3rd trimester.
In the present study, we evaluate the serum level of common autoimmunologic markers in women with polycystic ovary syndrome (PCOS) and study their relationship with hormonal parameters. The study was an observational case-control study, done in a Tertiary referral hospital, the study included 50 women with polycystic ovary syndrome and 50 matched control. Serum levels of Antinuclear Antibody (ANA) and anti-double-stranded DNA (dsDNA) were significantly higher in polycystic ovary syndrome women compared to control. Also, luteinizing hormone (LH), follicle stimulating hormone (FSH), and LH/FSH ratio were significantly higher in polycystic ovary syndrome women compared to control. dsDNA had excellent ability to differentiate PCOS from control (AUC=0.901) while ANA had good discrimination ability (AUC=0.809). There was a significant direct relationship between ANA, dsDNA, and TSH with FSH in PCOS women, also a significant direct relationship between ANA and TSH with LH, while DsDNA did not correlate with LH. In conclusion, there is a clear relationship between immunological markers (ANA, dsDNA) with polycystic ovary syndrome in various components of the disease, dsDNA offer better ability than ANA as a predictor of PCOS, indicating that dsDNA can be used as a non-invasive diagnostic tool for PCOS.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.